Advil hearts menstrual cramps

Share this article:
Does Advil heart menstrual cramps?
Does Advil heart menstrual cramps?

In what seems an unusual marketing approach, Advil's South Korean consumer website is representing menstrual pain with a heart. At least, that's what's depicted on the Pfizer online property.

What's more, the heart is being formed by a man, in this case Olympic swimmer Park Tae-Hwan, who is shown making the symbol with his hands to demonstrate so-called "period pain" (pictured).

Tae-Hwan takes the body language metaphor further, depicting other types of pain the NSAID purports to address: his hands at his temples (headache), a hand brushed up against a cheek (dental pain, or toothache), and arms behind back (back pain).

As to the connection between a heart and menstrual pain, which, after all, is a feminine problem, or why the drugmaker chose to cross gender lines and get a man for the job, Pfizer offered the following statement: “Advil helps consumers relieve minor aches and pains due to headache, backache, toothache, menstrual cramps, muscle aches, minor pain of arthritis, the common cold and temporarily reduces fever. It is available in over 45 countries.”

Tae-Hwan—or “Marine Boy”—as he's sometime referred, is a member of the South Korean national swimming team. He won a gold medal in the 400-meter freestyle and picked up a silver medal in the 200-meter freestyle at the 2008 Summer Olympics in Beijing.

Pfizer launched Advil's Liqui-Gel formulation in South Korea this past December. Worldwide sales for Pfizer's consumer healthcare unit came in at $943 million for 2013, a 2% increase vs. the year prior.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...